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ABSTRACT
Soluble vascular cell adhesion molecule-1 (sVCAM-1), intercellular cell adhesion 
molecule 1 (sICAM-1), and E-selectin are biomarkers reflecting endothelial activation 
(EA), a key event in atherosclerosis. High-density lipoprotein cholesterol (HDL-c) is 
protective against atherosclerosis by reverse cholesterol transport (RCT) but its 
association with EA is not well established. ATP-binding Cassette Transporter A1 
(ABCA1) is the main transport protein in RCT and its gene variants have been linked to 
low HDL-c concentration. Thus, this study aimed to (a) compare the concentration of 
biomarkers of EA between low HDL-c subjects and normal controls (NC), (b) examine 
the correlation and association between HDL-c and biomarkers of EA, (c) investigate 
whether HDL-c concentration is an independent predictor for these biomarkers, and (d) 
determine the genetic variants of ABCA1. A total of 207 subjects with low HDL-c and 
215 age-, gender-, ethnic-, smoking-, diabetic- and blood pressure-matched NC were 
recruited. Fasting blood samples were collected for biomarkers of EA and DNA 
extraction. Targeted regions oiABCAl gene were amplified and sequenced. The detection 
of the SNPs were analysed using BioEdit. Subjects with low HDL-c had greater 
concentrations EA biomarkers compared to controls. There were significant negative 
correlations and association between HDL-c concentration and EA biomarkers. HDL-c 
was an independent predictor for sVCAM-1. DNA sequencing of ABCA1 revealed six 
genetic variants and two SNPs were found to be significantly different between the low 
HDL-c subjects and NC in both genotype and allele frequencies. In conclusion, low 
serum HDL-c concentration is strongly correlated and associated with enhanced status of 
EA which strongly supports its role in the pathogenesis of atherosclerosis. The findings of 
genetic variation in ABCA1 suggest that this gene may play an important role in HDL 
deficiency amongst Malaysians.
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CHAPTER ONE
INTRODUCTION
1.1 RESEARCH BACKGROUND
Approximately $110 billion has been spent in the year 2010 alone for the cost 
of health care services, medications and loss of productivity in the US due to coronary 
artery disease (CAD), and by 2020 (Chockalingam et al., 2000) it is estimated that 
CAD will be the number one cause of disability and death worldwide which is nearly 
25 million of death (Murray & Lopez, 1997). According to The National Health and 
Morbidity Survey in 2011, Malaysia was reported as having a high prevalence of 
chronic disease including high cholesterol. In 2010, about 40% of death in Malaysia 
was estimated to be caused by chronic diseases. Whilst, data from World of Health 
Organization published in 2014, CHD death in Malaysia reached 29,363 or 23.10% of 
total death in which the death rate is 150.11 per 100,000  of population.
To date, CAD remains one of the major causes of death in the developed and 
developing countries (Xu et al., 2013) and is commonly due to atherosclerosis, a 
systemic and complex disease in which lipid and fibrous material accumulate within 
the intimal layer of large to medium-sized arteries. It is also the most important and 
common underlying cause of myocardial infarction, ischaemic stroke, and peripheral 
vascular diseases apart from being the major cause of chronic heart failure and 
vascular dementia. It can start as early as foetal life (Palinski & Napoli, 2002), 
progressing slowly throughout childhood and adolescence and accelerating in adult 
life. It also involves indolent inflammation, endothelial activation, oxidative stress and 
prothrombogenesis (Virmani, Kolodgie, Burke, Farb, & Schwartz, 2000).
Inflammation, endothelial activation, oxidative stress and prothrombogenesis 
are significant contributors to the development and progression of atherosclerosis. 
Several biomarkers have been established to reflect the status of these processes. 
Biomarkers such as high sensitivity C-reactive protein (hsCRP) and Interleukin-6 (IL- 
6) are indicators of inflammation (Schuett, Luchtefeld, Grothusen, Grote, & Schieffer,
2009), while endothelial activation is reflected through the various adhesion 
molecules such as soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble
1
